| Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies J Gertner-Dardenne, C Bonnafous, C Bezombes, AH Capietto, ... Blood, The Journal of the American Society of Hematology 113 (20), 4875-4884, 2009 | 192 | 2009 |
| Nrf2 induces IL-17D to mediate tumor and virus surveillance R Saddawi-Konefka, R Seelige, ETE Gross, E Levy, SC Searles, ... Cell reports 16 (9), 2348-2358, 2016 | 123 | 2016 |
| Interleukin-17D mediates tumor rejection through recruitment of natural killer cells T O’Sullivan, R Saddawi-Konefka, E Gross, M Tran, SP Mayfield, H Ikeda, ... Cell reports 7 (4), 989-998, 2014 | 93 | 2014 |
| Rituximab inhibits B-cell receptor signaling S Kheirallah, P Caron, E Gross, A Quillet-Mary, J Bertrand-Michel, ... Blood, The Journal of the American Society of Hematology 115 (5), 985-994, 2010 | 89 | 2010 |
| Cancer immunosurveillance and immunoediting by natural killer cells E Gross, JB Sunwoo, JD Bui The Cancer Journal 19 (6), 483-489, 2013 | 80 | 2013 |
| eIF5A-PEAK1 signaling regulates YAP1/TAZ protein expression and pancreatic cancer cell growth J Strnadel, S Choi, K Fujimura, H Wang, W Zhang, M Wyse, T Wright, ... Cancer research 77 (8), 1997-2007, 2017 | 66 | 2017 |
| Immune recovery after fludarabine–cyclophosphamide–rituximab treatment in B-chronic lymphocytic leukemia: implication for maintenance immunotherapy L Ysebaert, E Gross, E Kühlein, A Blanc, J Corre, JJ Fournié, G Laurent, ... Leukemia 24 (7), 1310-1316, 2010 | 66 | 2010 |
| Time-restricted feeding normalizes hyperinsulinemia to inhibit breast cancer in obese postmenopausal mouse models M Das, LG Ellies, D Kumar, C Sauceda, A Oberg, E Gross, T Mandt, ... Nature communications 12 (1), 565, 2021 | 57 | 2021 |
| Molecular Programming of Tumor-Infiltrating CD8+ T Cells and IL15 Resistance AL Doedens, MP Rubinstein, ET Gross, JA Best, DH Craig, MK Baker, ... Cancer immunology research 4 (9), 799-811, 2016 | 30 | 2016 |
| B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cells E Gross, FE L’Faqihi-Olive, L Ysebaert, M Brassac, S Struski, S Kheirallah, ... Leukemia 24 (11), 1885-1892, 2010 | 30 | 2010 |
| Tumor-expressed IL-17D recruits NK cells to reject tumors R Saddawi-Konefka, T O’Sullivan, ET Gross, A Washington Jr, JD Bui Oncoimmunology 3 (12), e954853, 2014 | 25 | 2014 |
| Endogenous IL-8 acts as a CD16 co-activator for natural killer-mediated anti-CD20 B cell depletion in chronic lymphocytic leukemia E Laprevotte, L Ysebaert, C Klein, W Valleron, A Blanc, E Gross, ... Leukemia Research 37 (4), 440-446, 2013 | 25 | 2013 |
| Immunosurveillance and immunoediting in MMTV-PyMT-induced mammary oncogenesis ETE Gross, S Han, P Vemu, CD Peinado, M Marsala, LG Ellies, JD Bui Oncoimmunology 6 (2), e1268310, 2017 | 17 | 2017 |
| Emerging concepts for the treatment of hematological malignancies with therapeutic monoclonal antibodies AH Capietto, S Keirallah, E Gross, N Dauguet, E Laprevotte, C Jean, ... Current drug targets 11 (7), 790-800, 2010 | 17 | 2010 |
| Isoflurane impacts murine melanoma growth in a sex-specific, immune-dependent manner: a brief report A Meier, ETE Gross, JM Schilling, R Seelige, Y Jung, E Santosa, ... Anesthesia & Analgesia 126 (6), 1910-1913, 2018 | 16 | 2018 |
| Cancer stem cells of differentiated B-cell malignancies: models and consequences E Gross, A Quillet-Mary, L Ysebaert, G Laurent, JJ Fournie Cancers 3 (2), 1566-1579, 2011 | 11 | 2011 |
| Identification and editing of stem-like cells in methylcholanthrene-induced sarcomas ETE Gross, CD Peinado, Y Jung, S Han, B Liu, EK Santosa, JD Bui Oncoimmunology 8 (1), e1404212, 2019 | 6 | 2019 |
| A tyrosine kinase protein interaction map reveals targetable EGFR network oncogenesis in lung cancer S Kaushik, F Haderk, X Zhao, HM Hu, KN Shah, GM Jang, V Olivas, ... bioRxiv, 2020.07. 02.185173, 2020 | 1 | 2020 |
| The Nrf2/Interleukin-17D axis as a novel target for cancer immune therapy R Seelige, R Saddawi-Konefka, ETE Gross, E Levy, SC Searles, ... The Journal of Immunology 198 (1_Supplement), 66.23-66.23, 2017 | 1 | 2017 |
| Ga101 Displays Higher Anti-Leukemic Activity Mainly Trough Enhanced Adcc in Chronic Lymphocytic Leukemia L Ysebaert, E Laprevotte, E Gross, C Klein, J Fournie, G Laurent, ... Haematologica-the Hematology Journal 95, 46-47, 2010 | 1 | 2010 |
